SCHEMBL7099437

SCHEMBL7099437

CCS(=O)(=O)N(C(=O)c1ccccc1)c1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c(F)cc1C#N

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCAT1 P54687 20/20 0.55
BCAT2 O15382 18/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7592627 0.87 BCAT2 (0.39) BCAT1BCAT2
SCHEMBL6697287 0.83 BCAT2 (0.35) BCAT1BCAT2
SCHEMBL7911705 0.76 BCAT2 (0.32) BCAT1BCAT2
SCHEMBL7027406 0.75 GPBAR1 (0.32)
SCHEMBL6702796 0.75 BCAT2 (0.37) BCAT1BCAT2
SCHEMBL6697595 0.75 MAPT (0.36) BCAT1BCAT2
SCHEMBL8327549 0.74 BCAT1 (0.55) BCAT1BCAT2
SCHEMBL5922790 0.73 BCAT1 (0.67) BCAT1BCAT2
SCHEMBL7923907 0.71 BCAT2 (0.32) BCAT1BCAT2
SCHEMBL6696728 0.71 BCAT2 (0.32) BCAT1BCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030032807-A1 Method for the production of 1-amino -3-aryl -uracils BAYER AKTIENGESELLSCHAFT (DE) 2003-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032807-A1 Method for the production of 1-amino -3-aryl -uracils NQO2, QARS1, NUDT1 BCAT1 378/4885BCAT2 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.